Computational phantom for red bone marrow dosimetry from incorporated beta emitters in a newborn baby

Author:

Sharagin PA1ORCID,Shishkina EA1ORCID,Tolstykh EI1ORCID

Affiliation:

1. Urals Research Center for Radiation Medicine of the Federal Medical-Biological Agency, Chelyabinsk, Russia

Abstract

Active (red) bone marrow (AM) exposure due to ingested bone-seeking radionuclides can lead to grave medical consequences. For example, a radioactive contamination of the Techa River in the 1950s caused exposure to AM for riverside residents and led to chronic radioactive exposure syndrome in some of them, with higher risk of leukemia. The main sources of the marrow exposure were the bone-seeking beta emitters 89,90Sr. Improving the dosimetry of AM internal exposure is an important step in clarifying the risks of chronic radiation exposure for riverside residents. To evaluate the energy absorbed by AM from incorporated 90Sr it is customary to use computational phantoms where radiation transport can be emulated. A phantom is a representative digital representation of skeletal bone geometry and AM The goal of this work was to develop a computational phantom of a newborn skeleton for dosimetry of AM from incorporated 90Sr. The researchers have used the Stochastic Parametric Skeletal Dosimetry method (SPSD), where hematopoietic sites were modeled as a set of phantoms of simple geometric shape describing individual skeletal bone areas. The AM content in the skeleton as well as the phantom parameters were evaluated on the basis of published measurements of real bones. As a result, a computational phantom of the main skeletal hematopoietic sites was generated for a newborn baby, including 34 phantoms of bone areas. The simulated phantom simulates the bone structure as well as the variability of skeletal parameters within the population and corresponds well to measurements of real bones.

Publisher

Federal Medical Biological Agency

Subject

Marketing,Pharmacy,Health Policy,Pharmaceutical Science,Pharmacology,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Drug Discovery,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Pharmacology,Pharmacology,Toxicology,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3